Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GATC Biotech Offers World´s Fastest Exome Sequencing Service

Published: Friday, June 07, 2013
Last Updated: Friday, June 07, 2013
Bookmark and Share
InView™ 1-Week Exome Diagnostic for the detection of cancerous cells or other genetic diseases.

GATC Biotech has designed InView™ 1-Week Exome Diagnostic especially for diagnostic purposes. This service enables early detection of multiple genetic variants presumably responsible for diverse genetic disease markers within just 7 days, the world’s fastest turn-around time available.

With its DIN EN ISO/IEC 17025 certified Next Gen Sequencing laboratories, GATC Biotech offers this application e.g. for detection of cancerous cells or early detection of other genetic diseases.

The application supports clinicians to initiate urgent treatments and opens the way to a more personalized patient care in the field of cancer, metabolic dysfunctions and immunological diseases.

With a combination of standardized workflows and highest quality standards, InView™ 1-Week Exome Diagnostic is an overall solution for fast and reliable variant detection.

Focusing on the functional relevant coding regions, only approx. 1% of the human genome (the exome) needs to be sequenced. This provides an efficient advantage for diagnostics and clinical research.

“Next Generation Sequencing technologies have set a new level in the field of clinical research and diagnostics. 1-Week Exome Diagnostic is an all-in-one service delivering rapid results for early detection of diseases for our customers in diagnostics, clinical and pharmaceutical research”, tells Dr. Marcus Benz, COO at GATC Biotech.

Dr. Benz continued, “Being the leading service provider for NGS solutions, scientists can profit from our thorough experience in exome analysis while receiving accurate results in only 7 days.”

Essential requirements for the competence of analysis and calibration laboratories such as DIN EN ISO/IEC 17025 and DIN EN ISO 9001 by the national accreditation body for the Federal Republic of Germany (DAkkS) have been fulfilled by GATC Biotech’s NGS laboratories.

The application is based on Agilent SureSelectXT Human All Exon V5 enrichment and Illumina MiSeq.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GATC Biotech Present Three Accredited NGS Platforms Under One Roof
With official accreditation of another sequencing platform, GATC Biotech presents the worldwide first trio of accredited NGS platforms under one roof.
Tuesday, April 23, 2013
Next Generation Sequencing of GATC Biotech AG Accredited by German DAkkS
GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation.
Monday, December 03, 2012
Scientific News
New Neurodevelopmental Syndrome Identified
Study pinpoints underlying genetic mutations, raising hopes for targeted therapies.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Gene Behind Rare Childhood Syndrome Identified
Online activism by one patient’s mother spurred research collaboration which led to the identification of a new genetic syndrome.
Resilience Project Identifies Rare Unaffected Individuals
Researchers from Mount Sinai and Sage Bionetworks report analysis of nearly 600,000 genomes for resilience project.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Virus Causing Tilapia Die-Offs Identified
Discovery of the virus causing Tilapia die-offs in Israel and Ecuador points the way to protecting a fish that feeds multitudes.
Children With Cancer To Get New Gene Test
Pilot study will sequence 81 cancer genes in children’s tumours to help personalise cancer treatment.
How The Bat Got Its Wings
Finding may provide clues to human limb development and malformations.
Lupus Study Shows Precision Medicine’s Potential to Define the Genetics of Autoimmune Disease
Researchers at UT Southwestern have used next-generation DNA sequencing technology to identify more than 1,000 gene variants that affect susceptibility to SLE.
Illuminating the Broad Spectrum of Disease
PRISM efficiently tests drug compounds in multiple cell lines simultaneously, accelerating discovery of targeted therapies in the service of precision medicine.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!